MUFG Securities EMEA plc
Broker-DealerPosition in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1597694
LONDON, X0
Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,034,360
-$3,930,390 QoQ
Shares Held
6,758
-54.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#328
of 784 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MUFG Securities EMEA plc holds $54,340,047 across 8 Biotechnology names. ALNY ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
180,500 | $23,957,765 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
22,809 | $11,329,914 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
49,043 | $9,184,773 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,126 | $5,690,426 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
6,758 | $2,034,360 | |
| 6 | MRNA |
Moderna, Inc.
|
13,822 | $967,954 | |
| 7 | INCY |
Incyte Corp
|
6,546 | $742,054 | |
| 8 | TECH |
BIO-TECHNE Corp
|
6,126 | $432,801 |
All Filings in ALNY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,034,360 | 6,758 | Shares | Defined | 2026-08-12 | |
| 2025-12-31 | $5,964,750 | 15,000 | Shares | Defined | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||